KTN's online platform helps you to make the connections you need

 

The Knowledge Transfer Network (KTN) has refreshed its online platform to intelligently connect you to relevant events, funding, thought pieces and specialist staff to help your business innovate and grow.

You can discover content using your area of interest, from Defence Security to transport; from space to health – all major UK economic sectors are covered. Once you have selected your interests, using our intelligent tagging system, we will then display rich and relevant content related to your area, often from surprising sources.

An example might be new satellite technology from the space sector that is applicable in the agri-food sector. KTN-UK.co.uk will help you form these unusual and valuable connections.

All content on the platform has been carefully curated by our team of innovation specialists – not by an automated algorithm – so you can be confident that KTN is connecting you to the most relevant cutting-edge information.

 

The move also marks a closer alignment with our main funder, Innovate UK , with the website branding making a clear visual link. Knowledge Transfer Network is Innovate UK's innovation network partner, and also works with other funders to provide innovation networking services and fulfil our mission to drive UK growth.

We link new ideas and opportunities with expertise, markets and finance through our network of businesses, universities, funders and investors. From agri-food to autonomous systems and from energy to design, KTN combines expertise in all sectors with the ability to cross boundaries. Connecting with KTN can lead to potential partners, horizon-expanding events and innovation insights relevant to your needs.

Visit our people pages to connect directly with expertise in your sector.

Visit the KTN refreshed online platfom here

Entries with tag medbio .

Open Funding calls from Innovate UK and H2020 - opportunities for medical biotechnology and advanced therapies

With Innovate UK’s delivery plan for this year comes a number of calls that are relevant to our sector - the MedBio team highlight here those we think that your organisation should be looking at in terms of opportunities for funding and collaboration- and we are here to help with taking these ideas further into proposals - please contact  KTN  to discuss. The scope,...
Read More About Open Funding calls from Innovate UK and H2020 - opportunities for medical biotechnology and advanced therapies »

Space for Innovation

Space for Innovation 14-15 September, London A unique opportunity to build cross-sector relationships, learn, and explore how research in the unique environment of space is creating opportunities to meet key challenges here on Earth, and how you could get involved. A cross-section of expert speakers will give perspectives – including first-hand case studies – showing how...
Read More About Space for Innovation »

BIA publishes new report on UK biotech financing

The Bioindustry Association (BIA), working in partnership with Evaluate and the London Stock Exchange (LSE), has published a new report -  Money, momentum and maturity: UK biotech financing and deals in 2015/16  - looking at trends in follow-on funding, venture capital activity, the strength of the R&D pipeline and rate of regulatory approvals. 2015 saw an...
Read More About BIA publishes new report on UK biotech financing »

The Cell And Gene Therapy Catapult and University of Aberdeen Launch Islexa to Develop Novel Diabetes Technology

The Cell and Gene Therapy Catapult (CGT) and University of Aberdeen, UK, announce the creation of Islexa, a new company developing a novel technology to produce laboratory grown islets, the organoids responsible for insulin production.  The technology could bring the option of an islet transplant to thousands more patients with type I diabetes. Currently in the UK, only 30-50...
Read More About The Cell And Gene Therapy Catapult and University of Aberdeen Launch Islexa to Develop Novel Diabetes Technology »

Manufacturing and materials competition

Innovate UK has announced the opening of its Manufacturing and materials competition, offering support totalling up to £15 million for manufacturing and materials projects that could lead to increased productivity, competitiveness and growth, especially for SMEs. The type of projects Innovate UK seeks to support are those that focus on technical feasibility, industrial research or...
Read More About Manufacturing and materials competition »

Ontario delegation signs Israel technology deals

A delegation of 130 businessmen, researchers, and government officials from Ontario, Canada is visiting Israel. Ontario Province Premier Kathleen Wynne, who arrived on Sunday, is also scheduled to visit the Palestinian Authority. The visit is designed to strengthen cooperation between the two countries, with an emphasis on technology and the life sciences. Canada openly admires Israeli...
Read More About Ontario delegation signs Israel technology deals »

Biomedical Engineering Innovation Workshop

Fundamentals of CAD and Programming for medical device development. 24 & 25 August 2016 Department of Biomedical Engineering, University of Strathclyde, Wolfson Centre, 106 Rottenrow, Glasgow G4 ONW A two-day CPD hands-on workshop for clinicians, businesses and students in the medical device community looking to acquire and apply crucial skills for medical...
Read More About Biomedical Engineering Innovation Workshop »

The future of biopharmaceutical formulation - making better products with novel approaches

KTN Biopharmaceutical Formulation Group The future of biopharmaceutical formulation - making better products with novel approaches UCL, London Thursday 7th July, 2016 The KTN’s Biopharmaceutical Formulation Group will meet on 7th July at an event hosted by the EPSRC Centre for Innovative Manufacturing at UCL. The event is an opportunity to hear from industry and academia in...
Read More About The future of biopharmaceutical formulation - making better products with novel approaches »

Funding Opportunities for SMEs in the Healthcare Sector: Webinar

    Funding Opportunities for SMEs in the Healthcare Sector - Webinar T he Cell and Gene Therapy Catapult, the Knowledge Transfer Network and H2020 National Contact Points will deliver a webinar on 30 June 2016 to highlight the forthcoming opportunities in Horizon 2020 Healthcare...
Read More About Funding Opportunities for SMEs in the Healthcare Sector: Webinar »

Medicines Discovery – mapping the UK innovation landscape

The Knowledge Transfer Network (KTN) has today launched a  Medicines Discovery UK Landscape .  This new tool  is designed to map the innovation landscape in medicines discovery - showcasing the UK capabilities and enabling added leverage from external collaborations, from outsourcing to strategic partnerships. Dr Alexander Henzing,  Knowledge Transfer Manager at...
Read More About Medicines Discovery – mapping the UK innovation landscape »

New funding to tackle antimicrobial resistance: behaviour within and beyond the healthcare setting

The Economic and Social Research Council (ESRC), the National Institute for Health Research (NIHR), Arts and Humanities Research Council (AHRC), the Medical Research Council (MRC), the Department for Environment, Food and Rural Affairs (Defra) and the Veterinary Medicines Directorate (VMD) are inviting applications for cross disciplinary proposals on the topic of behaviour relating to...
Read More About New funding to tackle antimicrobial resistance: behaviour within and beyond the healthcare setting »

Biotech sector catalysed by £1.7m Edinburgh facility

A £1.7 million centre offering large-scale bioprocessing facilities has opened in Edinburgh, the first facility of its kind in the UK and aiming to help businesses test and commercialise their concepts. Known as FlexBio, the Flexible Downstream Bioprocessing Centre at Heriot-Watt University will focus on research and projects that are ready to “scale up”, enabling them to carry...
Read More About Biotech sector catalysed by £1.7m Edinburgh facility »

Advanced Therapies and Medicinal Products Ministerial Taskforce Update

The Advanced Therapies Manufacturing Taskforce originated from the work of the  Medicines Manufacturing Industry Partership  (MMIP), it is co-chaired by George Freeman MP, Minister for Life Sciences, and by me, the Chair of the MMIP. It is a short-term group which will meet three times over 2016 with the aim of anchoring advanced therapy manufacturing and its associated supply...
Read More About Advanced Therapies and Medicinal Products Ministerial Taskforce Update »

Bioscience impact and innovation competition winners announced

BBSRC Innovator of the Year 2016 is Professor Tom Brown, from the University of Oxford for his for high impact serial entrepreneurship in DNA chemistry and outstanding commitment to innovation. Innovator of the Year celebrates individuals and small teams who have harnessed the potential of their excellent research to help address real world challenges. Professor Brown also won...
Read More About Bioscience impact and innovation competition winners announced »

AstraZeneca launches integrated genomics approach to transform drug discovery and development

AstraZeneca and its global biologics research and development arm, MedImmune, have announced an integrated genomics initiative to transform drug discovery and development across its entire research and development pipeline. To read the article in full, please click here.   
Read More About AstraZeneca launches integrated genomics approach to transform drug discovery and development »

New Collaboration Opportunities In Regenerative Medicine

New Collaboration Opportunities in Regenerative Medicine and Addressing Challenges to Clinical Adoption of Cell and Gene Therapies New Hunts House Guy’s campus King’s College London London SE1 1UL 14 th June 2016 The KTN in collaboration with Innovate UK, Cell and Gene Therapy Catapult, Department of Health and Kings College London are holding an event...
Read More About New Collaboration Opportunities In Regenerative Medicine »

New company created to develop novel technology to treat diabetes

UK technology has potential to bring islet transplant therapy to thousands of patients with type 1 diabetes The Cell and Gene Therapy Catapult (CGT) and University of Aberdeen, UK, today announce the creation of Islexa, a new company developing a novel technology to produce laboratory grown islets, the organoids responsible for insulin production. The technology could bring the...
Read More About New company created to develop novel technology to treat diabetes »

Open Innovate UK Funding competition

Innovate UK is to invest up to  £15 million  in innovation projects in manufacturing and/or materials. These projects will focus on identified technical or commercial challenges which are set out in the competition scope. The aim of this competition is to stimulate and broaden innovation in manufacturing and materials.  Projects need to be led by a business and must...
Read More About Open Innovate UK Funding competition »

Opportunities for IB & SynBio in the New Innovate UK Delivery Plan

Innovate UK has recently published its new  Delivery Plan,  outlining the main ways in which it will invest around £561M in helping businesses to innovate and grow in the financial year 2016 to 2017, including: two broad Health and Life Sciences competitions two broad Manufacturing and Materials competitions two ‘open’ funding competitions...
Read More About Opportunities for IB & SynBio in the New Innovate UK Delivery Plan »

Overcoming Cellular Barriers: Implications for Industrial Biotechnology

Overcoming Cellular Barriers: Implications for Industrial Biotechnology July 6th and 7th 2016, Birmingham Hilton Metropole The function of membranes in bacterial, yeast and mammalian cell factories are an important but underappreciated parameter in optimizing recombinant protein quality and yields.  In addition, the delivery of a therapeutic protein to its target...
Read More About Overcoming Cellular Barriers: Implications for Industrial Biotechnology »

MRC announces cross-council awards worth nearly £10m to tackle antibiotic resistance

Three large collaborative grants, totalling £9.5m, have been announced by the MRC as part of a cross-council initiative to tackle antimicrobial resistance (AMR). The awards together mark one of the biggest investments into AMR since the initiative launched and will use new technology to exploit natural compounds, develop a tool to offer better and faster diagnostics and explore how the...
Read More About MRC announces cross-council awards worth nearly £10m to tackle antibiotic resistance »

Oxstem closes record £16.9M fundraising round to design Stem Cell drugs to treat age-related disease

One of the most ambitious Oxford spinouts to date is on route to becoming a powerhouse in age-related regenerative medicine, developing drugs which can treat cancer, neurodegenerative diseases, heart failure, macular degeneration and other major age-related conditions. OxStem has raised a record £16.9m, and established strategic partnerships with world class biotechnology companies and...
Read More About Oxstem closes record £16.9M fundraising round to design Stem Cell drugs to treat age-related disease »

Project Activation at the National Formulation Centre - webinar

Project Activation at the National Formulation Centre - webinar 24th May In the 2014 Autumn Statement, the Chancellor of the Exchequer awarded the Centre for Process Innovation (CPI) £28 million to establish the National Formulation Centre (NFC), part of the High Value Manufacturing Catapult, to be based at NetPark, Sedgefield. It was announced that 'the new centre would bring...
Read More About Project Activation at the National Formulation Centre - webinar »

MedImmune and Regeneron Enter into Licensing Agreement for the Development of Antibody Drug Conjugates to Treat Cancer

MedImmune, the global biologics research and development arm of AstraZeneca and Regeneron Pharmaceuticals, Inc., today announced that they have entered into a licensing agreement under which Regeneron will use MedImmune’s pyrrolobenzodiazepine (PBD)-based warhead and linker technology to produce antibody-drug conjugates (ADCs) as potential cancer treatments. Regeneron will have exclusive...
Read More About MedImmune and Regeneron Enter into Licensing Agreement for the Development of Antibody Drug Conjugates to Treat Cancer »

Universal flu vaccine under development by Oxford spinout Vaccitech

Universal flu vaccine developed at Oxford already showing promise in Phase II clinical trials Large investment of £10m from Oxford Sciences Innovation Further programs include vaccines to boost cancer immunotherapies Oxford spin out company Vaccitech has launched today with £10m seed investment to develop a universal flu vaccine already showing promise in clinical...
Read More About Universal flu vaccine under development by Oxford spinout Vaccitech »
Showing 1 - 25 of 135 results.
Items per Page 25
of 6